BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 2, 2007
View Archived Issues
Neogenix selects GBI to manufacture its monoclonal antibody, NPC-1C
Read More
HemispheRx initiates Ampligen phase IIb trial for seasonal flu in Australia
Read More
Promising antitumor activity of thorium-labeled rituximab
Read More
Lupulone shows antiangiogenic activity in vitro and in vivo
Read More
Preliminary phase III results for CellCept in lupus nephritis
Read More
Alnylam advances RNAi therapeutic program into IND-enabling studies
Read More
Positive phase IIa results for Speedel's renin inhibitor for hypertension
Read More
Kythera completes enrollment for phase II trial of ATX-201
Read More
Roche and Merck & Co. patents report new agents for depression, psychosis and sleep disorders
Read More
Delcath includes fourth arm to phase II study of metastatic melanoma
Read More
New diagnostic agents reported by the Universities of Pittsburgh and Hong Kong
Read More
Acadia initiates phase IIb trial of ACP-104 for schizophrenia
Read More
Wilex begins enrollment for phase II trial for pancreatic cancer
Read More
New agents for endocrine-related disorders imparted in recent patent literature
Read More
FDA grants fast track designation for HCV-796
Read More
Alnylam initiates phase II trial of ALN-RSV01 for RSV
Read More
Organon signs asset purchase agreement for Kadmus' FAAH technology
Read More
New phase III trial studies sunitinib malate in metastatic colorectal cancer
Read More
Wyeth licenses osteoporosis drug targets from Galapagos collaboration
Read More
Largest international study of patients on dialysis begins in Europe
Read More
NanoEmulsion diclofenac cream begins phase IIa study
Read More
Amendment to Lialda agreement
Read More
Schering-Plough will not enter new exclusivity period to negotiate celgosivir license
Read More
Highly immunogenic ribosomal-based vaccine protects against Shigella infection
Read More
CH-1504 begins bioequivalence study
Read More
Priority review for Taxotere sNDA in head and neck cancer
Read More
ALT-2074 begins phase II study in patients with diabetes and Hp2-2
Read More
Vyvanse filed for ADHD in adults
Read More